Back to 
FARALLON CAPITAL MANAGEMENT, L.L.C.
FARALLON CAPITAL MANAGEMENT, L.L.C.
FPRXShowing 0 of 3 quarters
Position history for FARALLON CAPITAL MANAGEMENT, L.L.C.'s holdings in FIVE PRIME THERAPEUTICS INC
As of its Q1 2021 13F, Farallon Capital Management held 501,618 shares of FPRX (Five Prime Therapeutics), worth $18.9M. Farallon Capital Management's 13F filings listed FPRX from Q4 2020 to Q1 2021, 2 quarterly filings. FPRX was 0.1% of Farallon Capital Management's reported 13F portfolio.
Current Value
-
Current Shares
-
Total Value Change
$0
Total Shares Change
0
No position history available for this security.
Other major holders of FPRX: Magnetar Financial LLC, RA CAPITAL MANAGEMENT, L.P., STATE STREET CORP, DIMENSIONAL FUND ADVISORS LP, RTW INVESTMENTS, LP